RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Botanix Pharmaceuticals - Stock

Botanix Pharmaceuticals ROA 2024

Botanix Pharmaceuticals ROA

-0.37

Ticker

BOT.AX

ISIN

AU000000BOT2

WKN

A2ANJ5

In 2024, Botanix Pharmaceuticals's return on assets (ROA) was -0.37, a -60.72% increase from the -0.94 ROA in the previous year.

Botanix Pharmaceuticals Aktienanalyse

What does Botanix Pharmaceuticals do?

Botanix Pharmaceuticals Ltd is an Australian company specializing in the research and development of innovative therapies based on synthetic cannabinoids. The company was founded in 2014 by a team of experts and is headquartered in Perth, Western Australia. The history of Botanix Pharmaceuticals began with the discovery of the medical properties of cannabinoids derived from the hemp plant. Cannabinoids have a wide therapeutic potential, ranging from pain and inflammation relief to the treatment of seizure disorders and anxiety. Botanix Pharmaceuticals utilizes these properties to develop innovative product candidates that have high efficacy and tolerability. The business model of Botanix Pharmaceuticals is based on the concept of targeted treatment for diseases and conditions where traditional therapies are insufficient or cause unwanted side effects. The company develops and produces medications based on synthetic cannabinoids that target specific disease states and indications. Botanix Pharmaceuticals specializes in two areas. Firstly, it focuses on the development of topical products, such as ointments and creams, that are applied to the skin. These products are particularly effective in treating skin conditions such as acne or psoriasis. Secondly, the company is working on the development of medications for the treatment of internal conditions such as epilepsy or chronic obstructive pulmonary disease (COPD). In the field of topical products, Botanix Pharmaceuticals has already achieved significant success. The company has a promising pipeline of product candidates for various applications, including acne, psoriasis, atopic dermatitis, and bacterial infections. One promising drug candidate is BTX 1503, which was developed for the treatment of severe acne. It contains the synthetic cannabinoid BTX 1308, which possesses anti-inflammatory and antimicrobial properties. BTX 1503 has already demonstrated high efficacy and tolerability in clinical studies. In the field of internal conditions, Botanix Pharmaceuticals collaborates closely with leading institutions and research facilities to develop innovative therapies for seizure disorders and COPD. One promising product candidate is BTX 1801, which was developed for the treatment of severe epilepsy. BTX 1801 contains the synthetic cannabinoid BTX 1204, which has shown high efficacy and tolerability in the treatment of seizures. Botanix Pharmaceuticals is an innovative company that develops highly effective and tolerable medications based on synthetic cannabinoids. The company has already achieved remarkable success in a short period and has established itself as a leading player in the industry. With its pipeline of promising product candidates and its close collaboration with renowned research institutions, Botanix Pharmaceuticals is well-positioned to develop further innovative therapies in the future. Botanix Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Botanix Pharmaceuticals's Return on Assets (ROA)

Botanix Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Botanix Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Botanix Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Botanix Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Botanix Pharmaceuticals stock

What is the Return on Assets (ROA) of Botanix Pharmaceuticals this year?

The Return on Assets (ROA) of Botanix Pharmaceuticals is -0.37 undefined this year.

What was the ROA of Botanix Pharmaceuticals compared to the previous year?

The ROA of Botanix Pharmaceuticals has increased by -60.72% compared to the previous year.

What consequences do high ROA have for investors of Botanix Pharmaceuticals?

A high ROA is advantageous for investors of Botanix Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Botanix Pharmaceuticals?

A low ROA can be unfavorable for investors of Botanix Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Botanix Pharmaceuticals affect the company?

An increase in ROA of Botanix Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Botanix Pharmaceuticals impact the company?

A reduction in the ROA of Botanix Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Botanix Pharmaceuticals?

Some factors that can influence the ROA of Botanix Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Botanix Pharmaceuticals important for investors?

The ROA of Botanix Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Botanix Pharmaceuticals take to improve ROA?

To improve ROA, Botanix Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Botanix Pharmaceuticals pay?

Over the past 12 months, Botanix Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Botanix Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Botanix Pharmaceuticals?

The current dividend yield of Botanix Pharmaceuticals is .

When does Botanix Pharmaceuticals pay dividends?

Botanix Pharmaceuticals pays a quarterly dividend. This is distributed in the months of April, October, April, November.

How secure is the dividend of Botanix Pharmaceuticals?

Botanix Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Botanix Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Botanix Pharmaceuticals located?

Botanix Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Botanix Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Botanix Pharmaceuticals from 10/25/1996 amounting to 0.048 AUD, you needed to have the stock in your portfolio before the ex-date on 10/3/1996.

When did Botanix Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/25/1996.

What was the dividend of Botanix Pharmaceuticals in the year 2023?

In the year 2023, Botanix Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Botanix Pharmaceuticals pay out the dividend?

The dividends of Botanix Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Botanix Pharmaceuticals

Our stock analysis for Botanix Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Botanix Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.